Clinical trials
Proteomics clinical trials
Below are recruiting proteomics clinical trials, each written for real people, not researchers. We’re tracking 64 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07500324Recruiting
Searching for new markers in age-related eye diseases
This study looks for proteins in the blood and eye fluids that may help doctors better understand and monitor three common eye conditions: age-related macular degeneration, diabetic retinopathy, and retinal detachment. If you have one of these conditions, or if you are a healthy control with no retinal disease, you may be able to help by giving a small sample of blood or fluid from your eye during a routine procedure.
Roma, ItalyAges 18 years+ - NCT06771427Recruiting
Exosomes for Sjogren's and Dry Eye
This study looks at tiny particles called exosomes in tears to find new ways to diagnose or treat Sjogren's syndrome and dry eye disease. It may help people with these conditions by learning more about what causes them.
Taipei, TaiwanAges 20–75 - NCT06787963Recruiting
Breast milk proteins study for healthy moms
This study looks at the small proteins and peptides in breast milk and how they change over time. It aims to understand the health benefits of these components for breastfed babies, particularly when moms exclusively breastfeed for 4 months.
Córdoba, CórdobaAges birth–4 months - NCT07358026Recruiting
Early pregnancy study: health before conception
This study follows women and their partners before pregnancy to understand how health before conception affects early development. It is for people planning a pregnancy who are generally healthy.
ChiguayanteAges 18–40 - NCT07343661Enrolling by invitationPhase 4
Mepolizumab study for asthma or EGPA
This trial tests how well mepolizumab works for people with asthma or a related condition called EGPA, and looks for markers in the blood that may predict organ damage or treatment response.
Cagliari, CagliariAges 18 years+ - NCT07329712Recruiting
Light therapy for dry eye: tear protein study
This trial tests whether low-level light therapy can improve dry eye disease by measuring changes in tear proteins. It may help people with chronic dry eye who are interested in a non-drug treatment.
SingaporeAges 21 years+ - NCT06884163Recruiting
Hand Eczema Study: Understanding the Immune System at Work
This study examines the immune cells and proteins in chronic hand eczema samples. By comparing skin from affected and healthy areas, researchers hope to find new targets for treatment.
RomeAges 18–65 - NCT06382103Recruiting
Liver cancer study after surgery or pre-surgery therapy
This study looks at genetic markers in the blood of people with liver cancer who are having surgery, either right away or after some treatment first. It aims to find out why some patients do better, which could help personalize care.
ShanghaiAges Any age - NCT06900270Recruiting
Comparing blood markers in coronary artery disease
This study looks at blood proteins and other molecules in people with different types of coronary artery disease. The goal is to see how these markers differ between those with blocked arteries, those with narrowed arteries, and those with no artery disease. This may help doctors better understand the disease and improve treatment.
São Paulo, São PauloAges 50–80 - NCT07250477RecruitingPhase 2
Guided immunotherapy for advanced lung cancer
This trial tests whether using a blood test to guide treatment can improve outcomes for people with advanced non-small cell lung cancer who are starting immunotherapy for the first time. Participants will receive standard immunotherapy tailored to their individual risk profile.
Chico, CaliforniaAges 18 years+ - NCT07253701Recruiting
Epilepsy and gut bacteria: understanding treatment response
This study looks at how the bacteria in your gut relate to how well epilepsy treatments work. It compares people with newly diagnosed epilepsy (who haven't yet started medicine) to healthy people without epilepsy.
GothenburgAges 2–79 - NCT07246460Recruiting
Ultrasound and protein tests to see if guselkumab works for Crohn's
This study tests whether guselkumab (a targeted drug) can effectively treat Crohn's disease in the ileum (last part of the small intestine). You will have ultrasound scans and blood tests to measure your response, which may help find the right dose and monitor for bowel healing.
Calgary, AlbertaAges Up to 80 years - NCT07245888Recruiting
Studying pneumonia in ventilated ICU patients
This study looks at different types of lung infections in ICU patients on breathing machines. By analyzing fluid from your lungs, researchers hope to better understand pneumonia and improve treatment.
LimogesAges 18 years+ - NCT06924463Recruiting
Protein Study of Rhabdomyosarcoma in Young People
This study uses a special machine to find unique protein patterns in rhabdomyosarcoma tumor samples from children and young adults. By analyzing leftover tissue from past biopsies or surgeries, researchers hope to better understand the disease and improve future treatments.
Lille, NordAges birth–25 years - NCT07144228Recruiting
Platelet test for finding and tracking prostate cancer
This trial studies a new blood test that looks at platelets (a part of your blood) to help find prostate cancer or keep track of it. You may join if you are a man over 40 with a suspicion of prostate cancer who has not been treated for it before.
Durham, North CarolinaAges 40 years+ - NCT07119580Recruiting
Glaucoma, eye surface health, and tear proteins
This study looks at how glaucoma and its treatments affect the surface of the eye and proteins in tears. It may help find better ways to manage eye health in people with glaucoma.
HsinchuAges 18 years+ - NCT05650905Recruiting
Eye and blood-vessel function study after COVID-19
This study measures how well the nerves in your retina and the tiny blood vessels in your eye “couple” (work together) after COVID-19. It may help researchers understand eye-related effects of COVID-19 and long COVID, and how these processes change over time.
Vienna, State of ViennaAges 18 years+ - NCT07026552Recruiting
Ligament study for lumbar spinal stenosis
This study looks at the ligament in your lower back to understand how lumbar spinal stenosis develops. It involves analyzing tissue samples and may help find better ways to treat this condition.
Rome, RMAges 50–85 - NCT06954090Enrolling by invitationPhase 4
Urine test to guide early treatment in type 2 diabetes
This study looks at whether a urine test can help doctors choose the right medicines earlier to prevent kidney and heart problems in people with type 2 diabetes. You may join if you have type 2 diabetes but no severe heart failure.
Herlev, Hajdú-BiharAges 18 years+ - NCT06789653Recruiting
Using age-related proteins in early breast cancer
This study is testing a new way to use proteins in your blood that change with age to better understand early-stage breast cancer. It may help doctors personalize your care.
Chapel Hill, North CarolinaAges 22–66 - NCT03231241Recruiting
Study of worsening headaches using scans and blood testing
This study looks at why headaches can become long-lasting (“chronified”) by combining answers from online questionnaires, brain imaging, and blood protein tests. Your participation may help researchers find biological clues that could improve how headache problems are understood and treated.
Stanford, CaliforniaAges 18 years+ - NCT06430424Recruiting
Study of body markers in recurrent glioblastoma
This study looks at special markers in the blood and tumors of people whose glioblastoma has come back. It may help doctors understand why the cancer returns and how to treat it better.
BordeauxAges 18 years+ - NCT06642662Enrolling by invitation
Finding biomarkers in children after heart surgery
This study looks at proteins in the blood that may help doctors understand how children are recovering after heart surgery. It enrolls children under age 5 having certain types of heart repairs at Boston Children's Hospital.
Boston, MassachusettsAges 2 days–5 years - NCT06544083Recruiting
Blood test for early liver cancer detection
This trial is testing if a blood test can find liver cancer early. It may help people who are newly diagnosed or suspected to have liver cancer and have not started treatment yet.
Hangzhou, ZhejiangAges 18–75
Hear when a new Proteomics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for proteomics?
- Yes. Clin2 currently lists 64 recruiting proteomics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a proteomics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a proteomics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.